# Is CME Group Inc (CME) overvalued?

Source: https://www.equity-rank.com/is-it-overvalued/CME

**On Equity Rank's model estimate, CME trades 42% above its fair value.** CME Group Inc (CME) last closed at $305.89; the multi-method model fair value is $215.42.

| Price | Model fair value | Price vs model |
| --- | --- | --- |
| $305.89 | $215.42 | 42% above |

## What the answer rests on

- 5 of 11 valuation methods put CME's value above its price and 6 put it below, so the methods disagree.
- To justify today's price, CME's free cash flow would need to grow about 0.5% a year for ten years (a reverse discounted cash flow). Over the last three years it actually grew 12.2% a year.
- CME trades at 25.3 times its last year's earnings, against a median of 23.5 for 9 profitable Financial Data & Analytics companies.
- Over the past year the price sat below the model fair value on 14% of trading days. The gap ranged from 7% below to 74% above the model fair value.

## Read this before relying on it

The model fair value is an estimate from published financial statements. It is not a forecast of where the price goes, and it can be wrong. Within 10% either side we call it close to fair value: valuation models are not precise enough to read more into a smaller gap. Our own lists have no proven edge over the market yet; [the live record](https://www.equity-rank.com/track-record) shows every result, misses included.

Data as of Fri, Nov 6, 2026. Informational only — not investment advice.

[Every valuation method behind CME's fair value](https://www.equity-rank.com/stocks/CME) · [What prices assume](https://www.equity-rank.com/priced-in) · [Other companies](https://www.equity-rank.com/is-it-overvalued)

---

Fair value is a model estimate under stated assumptions — not a price target, not a prediction, and not a recommendation. This page is research information, not investment advice. Equity Rank is not a registered investment adviser.